Cytokinetics Inc. buy Barclays PLC
Start price
28.01.26
/
50%
€53.50
Target price
28.01.27
€72.55
Performance (%)
26.21%
Price
10:48
€67.52
Summary
This prediction is currently active. The prediction currently has a performance of 26.21%. This prediction currently runs until 28.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -2.322% | -2.322% |
| iShares Core DAX® | 3,26 % | 2,07 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % |
| iShares S&P 500 | 2,80 % | 2,25 % |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $87.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
08.05.25
08.05.25
€46.79
08.05.26
08.05.26
127.86%
09.05.26
09.05.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€33.60
24.04.25
24.04.25
€48.44
24.04.26
24.04.26
63.39%
25.04.26
25.04.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€46.40
23.05.24
23.05.24
€87.72
23.05.25
23.05.25
-42.24%
24.05.25
24.05.25